Caplight Directory>Investors>age1>Age1


age1

age1

San Francisco, Californiaage1.com

Overview

age1 is a venture capital firm that invests in and supports founders of longevity biotech companies. It focuses on early-stage investments, including pre-seed and seed rounds, in companies developing therapeutics, tools, and technologies that target aging and age-related diseases to extend healthy lifespans. The firm is a successor to The Longevity Fund and was co-founded by Laura Deming (founder of The Longevity Fund) and Dr. Alex Colville.

Portfolio Companies

8

Website

age1.com

Investments

CompanyDateStageLead
LoyalFeb 2026Series CLead
AerskaFeb 2026Series ALead
Skeletalis BioNov 2025SeedCo-investor
AerskaOct 2025SeedLead
General ProximityJan 2025SeedCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersSan Francisco, California
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.